T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8, D o h a 1 TEAP Update Presentation for MOP-20.

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 1

TEAPUpdate Presentation for MOP-20

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 2

TEAP/MTOCAssessment of Revised

Essential Use Nominations for MDIs

and Progress Report

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 3

Essential Use Nominations for MDIs

Recommend exemption for CFCs for MDIs for 92 tonnes.

--

2010

-

Recommend exemption for CFCs for MDIs for 248 tonnes (for single-moiety salbutamol to be sold within the Russian Federation).

Recommend exemption for CFCs for MDIs for 22 tonnes.

2009

United StatesRussian FederationEuropean Community

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 4

European Community Revised Essential Use Nomination for MDIs

• Reduction in CFCs nominated for 2009 (22 tonnes)– 60% intended for Italy; 40% for Article 5 Parties– Three active ingredients withdrawn

• New information submitted after OEWG-28 to support the nomination– Demonstrated inaccessibility of available stockpile

– Additional information to support volume and essentiality of the combination products to Italy, and on progress in reformulation

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 5

European Community Revised Essential Use Nomination for MDIs

• Most MTOC members do not consider these combination products an essential use

• However, given that 2009 is the final year of nomination, MTOC reluctantly recommends the nomination owing to:

– reformulation progress

– inaccessibility of available stockpile

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 6

United States Revised Essential Use Nomination for MDIs

• Significant reduction in CFCs nominated for 2010 (92 tonnes)– Two active ingredients withdrawn

• New information submitted after OEWG-28 to support the nomination– Claimed inaccessibility of available stockpile with required CFC mix

– Additional information to support volume and essentiality of epinephrine CFC MDI to United States, and on progress in reformulation

• Active moiety subject to US FDA rule-making, yet to be completed

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 7

United States Revised Essential Use Nomination for MDIs

• Some MTOC members did not consider epinephrine CFC MDIs an essential use

• MTOC members urge completion of development efforts by beginning of 2011, as planned by manufacturer

• MTOC reluctantly recommends the nomination owing to

– anticipated reformulation progress, and

– inaccessibility of available stockpile

• MTOC will not recommend CFC for epinephrine after 2010

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 8

Phase-out of CFC MDIs in A5 Parties

• Significant progress in transition from CFC MDI use in all A5 Parties, with a range of technically feasible alternatives available

• Mandated global CFC production phase-out 14 months away

• Many MLF projects to convert locally owned CFC MDI manufacturing are still in the early stages

• Pace of MLF-financed manufacturing conversion will determine the quantities of CFCs required after 2009

• Continued production of small amounts of pharmaceutical-grade CFCs after 2009 is likely to be impractical

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 9

Update Decision XVIII/16: Recommended Option

• A final CFC manufacturing campaign would provide:

– A clear target for ending CFC production

– Predictability for CFC producers

– Incentives for companies to switch manufacturing to CFC-free alternatives

• The date for a final campaign production can be set when:

– Timelines for project implementation are clear

– Projections of CFC requirements are known

• Final production campaign of pharma-grade CFCs feasible in 2011

– Requires planning and coordination

– Assumes conversion project implementation is not delayed further

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 10

TEAP / CTOCEssential Use Nomination of CFC-113 by

the Russian Federation

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 11

Background

• Decision XVIII/8 (MOP-18) approved 150 tonnes for 2007 as exemption for CFC-113 applications in the aerospace industry in the Russian Federation

• Decision XIX/14 authorized 140 tonnes for 2008 and 130 tonnes for 2009 provided that TEAP identifies no alternatives and noted that:

– Experts nominated by TEAP/CTOC will meet with Russian engineers to evaluate the applications and to recommend proven alternatives if possible

– The Russian Federation is ready to explore the availability of CFC-113 from global stocks

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 12

Conclusions

• The HCFCs (-122 and -141b) have been qualified in the laboratories to replace some uses, but their commercial use still faces significant approval process by various organisations

• Successful substitution by 2010 is possible but will require close cooperation between various organisations

• The compatibility of the HCFC alternatives with non-metallic materials remains an important issue

• Total CFC-113 phase-out will require significant research, testing and initiatives by the Russian space industry

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 13

Recommendations

• TEAP and its CTOC reaffirm 140 tonnes of CFC-113 for 2008 and 130 tonnes for 2009 based on progress made to date and work remaining to commercialise HCFC alternatives

• Quantities of CFC-113 are likely less necessary in future years provided the Russian Federation successfully implements:

– Replacement to HCFCs

– Flammable HC/alcohol blends in appropriately designed explosion-rated equipment

– Replacement of materials not compatible with HCFC solvents

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 14

TEAP/HTOCDecision XIX/16: Study on Regional

Imbalances in the Availability of Halons

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 15

Decision XIX/16 - Update

• The TEAP report is not ready for presentation at MOP-20 owing to the limited availability of country data and the late start of the MLF Banking Study– The MLF Banking Study commenced October 2008 and a peer

review draft is anticipated by end 2008– Additional country data has been received since OEWG-28, and

HTOC members have been obtaining additional data from their own regional contacts

• HTOC will meet in March 2009 to finalise the report for TEAP review and for presentation to the OEWG-29

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 16

TEAP / RTOC

Decision XIX/8

Application of HCFC Alternatives at High Ambient Temperatures

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 17

Decision XIX/8

At MOP-19 in Montreal, Decision XIX/8 was taken related to HCFC alternatives and specific climatic conditions:

• To request the TEAP to conduct a scoping study addressing the prospects for the promotion and acceptance of alternatives to HCFCs in the refrigeration and air conditioning sectors in Article 5 Parties, with specific reference to specific climatic conditions and unique operating conditions, such as those in mines that are not open pit mines, in some Article 5 Parties;

• To request the TEAP to provide a summary of the outcome of the study referred to in the preceding paragraph in its 2008 progress report with a view to identifying areas requiring more detailed study of the alternatives available and their applicability.

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 18

Status of scoping study

• Decision XIX/8 asks for guidance on the replacements for HCFC-22, which is a commonly used refrigerant under hot ambient conditions

• The RTOC co-chairs assembled an RTOC sub-committee (6 experts including 2 from an Article 5 Party)

• Delay in 2008 occurred due to– difficulties encountered in gathering accurate commercial product

data from different countries

– logistic difficulties related to the restructuring of the RTOC committee for the 2010 Assessment Report

– logistic difficulties in planning travels to South Africa

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 19

Analyses for the scoping study (1)

Analyses are being performed regarding the impacts of elevated temperatures when applying candidate HCFC alternative refrigerants (both commercialised and newly proposed ones) on:– capacity and efficiency in representative equipment (mostly via

cycle refrigeration models) – capacity and efficiency data from commercially available

equipment

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 20

Analyses for the scoping study (2)

Difficulties have been and are encountered where it concerns:• data gathering from applicable Article 5 Parties on the present

practices and the problems encountered • consistent analyses for unconventional refrigerant candidates• lack of reliable data for specialised equipment and the

servicing of this equipment

• Logistics, time scale and funding issues are prohibitive for the convening of TEAP/RTOC special-purpose meeting(s)

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 21

Timeline for completion

• The scoping study will be open for technical review after January 2009

• The scoping study will be part of the April/May TEAP 2009

Progress Report

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 22

Update of theUpdate of the

TEAP - 2008 Task Force on CTC EmissionsTEAP - 2008 Task Force on CTC Emissions

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 23

CTC emissions calculated from atmospheric abundances and reported production

Emissions/Production CTC

0.00

50,000.00

100,000.00

150,000.00

200,000.00

250,000.00

300,000.00

1999 2000 2001 2002 2003 2004 2005 2006

Year

CT

C O

DP

To

nn

es

Emissions ScienceProductionProd nA5Prod A5

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 24

Unexplained CTC emissions

• Recent atmospheric measurements of CTC concentrations have remained high despite phase-out

• To reconcile bottom-up and estimates from atmospheric concentrations the Task Force developed a model

• The model reconciles bottom-up and emission estimates for 1999, but cannot explain recent values

• Therefore TEAP and its CTOC conclude that there must be substantial unreported emissions

• CTOC will investigate what sources these might be

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 25

Model for CTC emissions

The model considers emissions arising from: • Total production• Feedstock uses • Controlled consumption

– Emissive uses– Process agents

• Imports• Destruction

The model is based on:• 1999-2006 figures reported to the Ozone Secretariat• Different emission factors for each step depending on

whether A5 or non-A5 Parties

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 26

Emissions from Bottom-Up and Atmospheric Models

Range CTC Emissions ODP Tonnes

0,00

20.000,00

40.000,00

60.000,00

80.000,00

100.000,00

120.000,00

1999 2000 2001 2002 2003 2004 2005 2006

Year

CT

C E

mis

sio

ns

Min Total Max Total Science

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 27

Conclusions

– The rapid decrease in model-estimated bottom-up emissions is significantly lower than emissions derived from atmospheric measurements for the range of scientifically determined atmospheric lifetimes

– The decrease in emissions from controlled uses seems to being compensated by a rapidly growing new source

– More work needs to be done, i.e., explore high growth products such as HCFC-22, which may require co-production of CTC with chloroform

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 28

TEAP

Administrative issues

T E A P a t M o n t r e a l P r o t o c o l M O P - 2 0, 1 6 - 2 0 N o v 2 0 0 8 , D o h a 29

TEAP/ TOC Organisation issues

• TEAP requests US $100 k budget for 2009– For travel and meeting expenses; never for consulting fees or

wages; only if approved by TEAP co-chairs & UNEP secretariat

– Without budget, TEAP and TOCs will be unable to complete assignments

• Sergey Kopylov proposed as Co-Chair of the Halons TOC– Nominated by the Russian Federation

– Recommended by TEAP

• Positions available– Experts in nutsedge control, orchard replant, forestry and nursery

propagation for the MBTOC

– Experts in aviation fire protection for the HTOC

– Experts in several refrigeration and AC sub-sectors (including high ambient temperature experts) for the RTOC